Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole Dose-Response in Trichuriasis and Hookworm Infections
NCT03527745Phase 2Completed
- Start
- Oct 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of albendazole in trichuriasis, hookworm infection. Started Oct 2018; status: completed.
02
Drugs
albendazole
03
Conditions
trichuriasishookworm infection
Beyond the preview
Go deeper on NCT03527745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03527745.